Soleno Therapeutics’ stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy the company.
Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.
Popular News
-
HMRC Connect system now holds 55bn data items in bid to tackle tax evasion
-
Qué tener en cuenta antes de hacer su presupuesto con el método de meter dinero en sobres
-
Bitwise files for XRP ETF via Delaware trust
-
How to Get a Debt Consolidation Loan With Bad Credit
-
European BSL and private credit markets hit record volumes in 2025
Latest News
Strategy resumes Bitcoin purchase, adding $330M in BTC
Strategy added 4,871 Bitcoin for about $330 million in the first week of April, restarting acquisitions after a brief pause...
New college graduates face a tough job market: Money moves to help
Chuck Savage | The Image Bank | Getty ImagesRead more CNBC personal finance coverage"For young people early in their career,...
Program Manager for Career Readiness and Lifelong Success
Requisition Number: 70769Location: Boulder, ColoradoCity: BoulderState: ColoradoEmployment Type: University StaffSchedule: Full-TimePosting Close Date: 07-Apr-2026Date Posted: 24-Mar-2026 Job Summary The College...
United Airlines wants even higher ticket prices. It’ll get them — with or without the Iran war.
United’s new ‘luxury’ strategy is a risky bet for investors when fares and complaints are sky-high.
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.